News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
DILLY STEPHEN GEORGE
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/09/2023 |
4
| DILLY STEPHEN GEORGE (See Remarks) has filed a Form 4 on CODEXIS, INC.|
Txns:
| Granted 289,000 shares
@ $0
Sold 28,088 shares
@ $4.6027, valued at
$129.3k
Sold 26,987 shares
@ $4.5552, valued at
$122.9k
|
|
| 02/21/2023 |
4
| DILLY STEPHEN GEORGE (See Remarks) has filed a Form 4 on CODEXIS, INC.|
Txns:
| Granted 112,500 shares
@ $0
Granted 337,500 options to buy
@ $5.44, valued at
$1.8M
|
|
| 08/03/2022 |
4
| DILLY STEPHEN GEORGE (See Remarks) has filed a Form 4 on CODEXIS, INC.|
Txns:
| Granted 700,000 options to buy
@ $6.73, valued at
$4.7M
|
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| DILLY STEPHEN GEORGE (Director) has filed a Form 4 on CODEXIS, INC.|
Txns:
| Granted 11,273 shares
@ $0 |
|
| 03/14/2022 |
4
| DILLY STEPHEN GEORGE (CEO and President) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 165,000 options to buy
@ $31.54, valued at
$5.2M
|
|
| 01/28/2022 |
4
| DILLY STEPHEN GEORGE (CEO and President) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 65,000 options to buy
@ $12.15, valued at
$789.8k
|
|
| 06/17/2021 |
4
| DILLY STEPHEN GEORGE (Director) has filed a Form 4 on CODEXIS, INC.|
Txns:
| Granted 4,796 shares
@ $0 |
|
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| DILLY STEPHEN GEORGE (Director) has filed a Form 4 on CODEXIS, INC.|
Txns:
| Granted 17,905 shares
@ $0 |
|
| 06/02/2020 |
4
| DILLY STEPHEN GEORGE (CEO and President) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 520,000 options to buy
@ $14.03, valued at
$7.3M
|
|
| 05/20/2020 |
4
| DILLY STEPHEN GEORGE (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 2,500 shares
@ $0
Granted 15,000 options to buy
@ $10.46, valued at
$156.9k
|
|
| 03/20/2020 |
4
| DILLY STEPHEN GEORGE (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Sold 35,000 shares
@ $6, valued at
$210k
Exercised 35,000 options to buy
@ $5.42, valued at
$189.7k
|
|
| 03/18/2020 |
4
| DILLY STEPHEN GEORGE (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Sold 15,000 shares
@ $6.0174, valued at
$90.3k
Exercised 15,000 options to buy
@ $5.42, valued at
$81.3k
|
|
| 06/12/2019 |
4
| DILLY STEPHEN GEORGE (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 2,500 shares
@ $0
Granted 15,000 options to buy
@ $9.38, valued at
$140.7k
|
|
| 06/13/2018 |
4
| DILLY STEPHEN GEORGE (President and CEO) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Sold 29,457 shares
@ $30.8348, valued at
$908.3k
Exercised 29,457 options to buy
@ $3.0221, valued at
$89k
|
|
| 06/12/2018 |
4
| DILLY STEPHEN GEORGE (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 2,500 shares
@ $0
Granted 15,000 options to buy
@ $15.65, valued at
$234.8k
|
|
| 06/08/2018 |
4
| DILLY STEPHEN GEORGE (President and CEO) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Sold 30,465 shares
@ $31.1955, valued at
$950.4k
Sold 32,098 shares
@ $30.9465, valued at
$993.3k
Sold 500 shares
@ $31.58, valued at
$15.8k
Sold 42,106 shares
@ $30.6966, valued at
$1.3M
Exercised 30,465 options to buy
@ $3.0221, valued at
$92.1k
Exercised 32,598 options to buy
@ $3.0221, valued at
$98.5k
Exercised 42,106 options to buy
@ $3.0221, valued at
$127.2k
|
|
| 06/05/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/25/2017 |
4
| DILLY STEPHEN GEORGE (See Remarks) has filed a Form 4 on Aimmune Therapeutics, Inc. |
| 10/18/2017 |
4
| DILLY STEPHEN GEORGE (President and CEO) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Sold 1,154 shares
@ $26.238, valued at
$30.3k
|
|
| 10/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2017 |
4
| DILLY STEPHEN GEORGE (President and CEO) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Gifted 41,075 shares
@ $0
Gifted 41,075 shares
@ $0
Gifted 10,328 shares
@ $0
Gifted 10,328 shares
@ $0
Gifted 41,075 shares
@ $0
Gifted 41,075 shares
@ $0
Gifted 10,328 shares
@ $0
Sold 100,000 shares
@ $25.0079, valued at
$2.5M
|
|
| 07/28/2017 |
4
| DILLY STEPHEN GEORGE (President and CEO) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Sold 50,000 shares
@ $21.4622, valued at
$1.1M
|
|
| 06/27/2017 |
4
| DILLY STEPHEN GEORGE (President and CEO) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Sold 49,400 shares
@ $20.2144, valued at
$998.6k
|
|
| 06/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/12/2017 |
4
| DILLY STEPHEN GEORGE (See Remarks) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Sold 600 shares
@ $20.15, valued at
$12.1k
|
|
| 02/24/2017 |
4
| DILLY STEPHEN GEORGE (See Remarks) has filed a Form 4 on Aimmune Therapeutics, Inc. |
| 11/15/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/15/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/26/2016 |
4
| DILLY STEPHEN GEORGE (See Remarks) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Granted 240,000 options to buy
@ $16.93, valued at
$4.1M
|
|
| 06/24/2015 |
4
| DILLY STEPHEN GEORGE (Director) has filed a Form 4 on SANGAMO BIOSCIENCES INC|
Txns:
| Granted 10,000 options to buy
@ $11.44, valued at
$114.4k
|
|
|
|
|